New drug may overcome treatment resistance in a high-risk children's cancer
- OPACC
- Jan 8, 2016
- 1 min read
Pediatric oncologists from The Children's Hospital of Philadelphia (CHOP) have reported their latest results in devising new treatments for stubbornly deadly forms of the childhood cancer neuroblastoma.
Comments